𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: Initial response and long-term results in 54 patients

✍ Scribed by Norbert Niederle; Thomas Moritz; Otto Kloke; Ursula Wandl; Dieter May; Reinhardt Becher; Thomas Franz; Bertram Opalka; Carl Gottfried Schmidt

Book ID
119157053
Publisher
Elsevier Science
Year
1991
Weight
1021 KB
Volume
27
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term response in accelerated-phase
Long-term response in accelerated-phase chronic myelogenous leukemia with protracted splenic irradiation and ?-interferon
✍ Girinsky, T.; Bonomi, M.; Bayle, C. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 40 KB πŸ‘ 2 views

Forming Assay From CD34 + Bone Marrow Cells Serum a BFU-E/10 2 CD34 + cells Control 1 50.2 Β± 4.6 Control 2 48.5 Β± 14.1 Before chemotherapy 24.4 Β± 6.2 b After chemotherapy 50.5 Β± 6.5 Values are means Β± SD of triplicate cultures. a Control 1; normal AB serum, Control 2; serum from a patient with AILD-

Therapy adapted to molecular response in
Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study
✍ Frank Neumann; Judith Markett; Roland Fenk; Monika Pooten; Anne Koch; Daniela Br πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 118 KB

## Abstract This study evaluates response‐adapted treatment of chronic myelogenous leukaemia (CML) in chronic phase using molecular response criteria. __bcr‐abl__/G6PDH ratios were assessed by Light‐Cycler quantitative real‐time polymerase chain reaction (PCR( in 277 peripheral blood samples from 3